Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...

Keytruda is set to lose exclusivity in 2028, meaning Summit may face competition from cheaper biosimilars. Meanwhile, other ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pharmaceutical imports to the U.S. surged in March as drugmakers stocked up ahead of potential U.S. tariffs on their products ...

We recently published a list of Billionaire Mario Gabelli’s 10 Large-Cap Stock Picks with Huge Upside Potential. In this ...

In recent months, drugmakers told Reuters they had taken the unusual step of sending more medicines by air to the US. Two of ...

Trials of IFx-Hu2.0 are initiating, looking to overcome checkpoint inhibitor resistance in Merkel cell carcinoma.

The US merchandise-trade deficit with Ireland soared to a record in March on a massive inflow of pharmaceuticals and ...

All the while, she bonded easily with patients and became their go-to person as they went through the expected stages of ...

During a live event, Daniel M. Geynisman, MD, and participants discussed which efficacy end points they value and how they ...

At this time, I would like to welcome everyone to the Jacobs fiscal second-quarter 2025 earnings conference call. (Operator Instructions) Thank you. And I would now like to turn the conference over to ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but will take place amid newly imposed scrutiny of COVID shots.